# Hour 23: 23:00-23:59 - Final Hour / Overnight Transition

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Hour 23 is the final hour of the 24-hour on-demand Physical AI oncology trial
simulation cycle. Two new patients arrive for overnight procedures, bringing
the cumulative unique patient count to 175 (PAT-ODMND-0001 through
PAT-ODMND-0175, including three carried-over patients P0003, P0004, P0005
from the prior day cycle). The facility transitions fully to night operations
under SSO-N2, with most robotic systems entering standby or scheduled
maintenance. Four patients are concurrently on-site at 23:59. No adverse
events occurred during this hour or across the entire 24-hour cycle.

This hour closes a successful demonstration of round-the-clock on-demand
oncology care delivery using 10 Physical AI robot types (29 total instances)
operating under the PSL framework. The 24-hour cycle validated that the
site can accommodate patient-chosen scheduling across all hours, including
overnight slots selected for work or caregiver schedule accommodation.

## 24-Hour Cycle Completion Summary

- Total unique patients served: 175
- Total adverse events: 0
- Total robot malfunctions requiring patient rescheduling: 0
- Total hours with at least 1 active procedure: 24 of 24
- Peak concurrent patients: reached during daytime hours
- Minimum concurrent patients: 4 (this hour, at 23:59)
- PSL site score progression: 63.4 (Hour 00 baseline) to 64.4 (Hour 23 final)
- RT Motion-Tracking Dim B increased by +0.1 this hour, confirming 24-hour
  coverage capability across the full cycle

## Site Status at 23:00

- Total patients on-site: 4 (2 overnight recovery/monitoring, 2 new arrivals)
- Active procedures: 0 (procedures begin at 23:15 and 23:40)
- Robots in active mode: 1 (COMPN-02, pediatric monitoring for P0173)
- Robots in standby mode: 27
- Robots in maintenance: 1 (SURG-01, preventive maintenance continues)
- Queue length: 0 across all stations
- Site safety officer on duty: SSO-N2 (night shift, assumed 23:00)

## New Patient Arrivals

| Patient ID | Time | Age | Sex | Cancer Type | Stage | ECOG | Robot Needed |
|------------|------|-----|-----|-------------|-------|------|--------------|
| PAT-ODMND-0174 | 23:15 | 52 | M | Colorectal cancer, liver metastases | IV | 1 | Imaging (8) |
| PAT-ODMND-0175 | 23:40 | 66 | F | NSCLC adenocarcinoma | IIIB | 1 | RT Motion-Tracking (7) |

Patient PAT-ODMND-0174 is a 52-year-old male with Stage IV colorectal cancer
with hepatic metastases presenting for surveillance imaging of known liver
lesions. He has been receiving FOLFOX chemotherapy (cycle 8 of 12) and requires
interval imaging to assess treatment response per RECIST 1.1 criteria. ECOG
performance status 1. He selected the 23:00-00:00 overnight window via the
patient portal to minimize time away from work. Informed consent for Physical
AI-assisted imaging previously obtained (consent ID IC-2026-1482) per
21 CFR 50.25 and ICH E6(R2) Section 4.8.

Patient PAT-ODMND-0175 is a 66-year-old female with Stage IIIB NSCLC
adenocarcinoma presenting for her 18th of 30 planned radiotherapy fractions
(2 Gy per fraction). She specifically chose the overnight slot to accommodate
her work schedule as a night-shift nurse, demonstrating the on-demand
scheduling model validated across this 24-hour cycle. ECOG performance
status 1. Informed consent previously obtained (consent ID IC-2026-1491)
per 21 CFR 50.25, including Physical AI robotic motion-tracking disclosure.

## Continuing Patients

| Patient ID | Age | Sex | Cancer Type | Status | Since |
|------------|-----|-----|-------------|--------|-------|
| PAT-ODMND-0154 | 58 | M | Esophageal adenocarcinoma | Post-surgical recovery | 20:30 this day |
| PAT-ODMND-0173 | 9 | F | Pediatric Ewing sarcoma | Overnight companion monitoring | 22:10 this day |

PAT-ODMND-0154 continues post-surgical recovery overnight, analogous to
PAT-ODMND-0003 from the start of the 24-hour cycle. Vital signs stable.
Recovery Bay 3. Nursing staff and telemetry monitoring active per standard
post-operative protocols. Anticipated discharge in the morning.

PAT-ODMND-0173 is a pediatric patient under overnight companion monitoring
with COMPN-02. Nightlight mode active. Heart rate monitoring via room sensors
within age-appropriate parameters. Parent present at bedside.

## Active Procedures This Hour

### Imaging Assessment (23:20-23:42)
- Patient: PAT-ODMND-0174
- Robot: IMAGE-02 (Imaging Assistant, Instance 2)
- Bay: Imaging Bay 2
- Procedure: Robotic abdominal CT with contrast for liver metastasis
  surveillance per RECIST 1.1
- Duration: 22 minutes (positioning 3 min, pre-contrast scan 5 min, contrast
  injection and arterial/portal phases 10 min, delayed phase 4 min)
- Contrast: Iohexol 100 mL IV, power injector at 3.0 mL/s
- Liver lesion count: 4 measurable lesions identified, consistent with prior
- Largest lesion: 2.8 cm (segment VII), stable from prior scan
- Sum of target lesion diameters: 7.2 cm (prior: 7.4 cm) - stable disease
- Motion artifacts: 0
- Image quality: Diagnostic
- Outcome: Successful completion. Images uploaded to PACS and digital twin.

Minute-by-minute summary (active procedure):
- 23:20 - Patient positioned supine, arms above head, breathing instructions
- 23:21 - Scout scan acquired, field of view set
- 23:22 - Robotic arm positions detector array, IMAGE-02 confirms alignment
- 23:23 - Non-contrast axial scan begins
- 23:27 - Non-contrast scan complete, IV access confirmed by nurse
- 23:28 - Power injector armed, contrast injection begins
- 23:29 - Bolus tracking engaged, aortic threshold reached
- 23:30 - Arterial phase scan acquired
- 23:32 - Portal venous phase scan acquired (70 s delay)
- 23:36 - Delayed phase scan acquired (5-minute delay)
- 23:38 - Patient table returned to start, IMAGE-02 arm retracted
- 23:40 - Patient assisted to seated position, IV removed
- 23:42 - Patient exits imaging bay. Procedure complete.

### RT Motion-Tracking Session (23:48-23:59+)
- Patient: PAT-ODMND-0175
- Robot: TRACK-02 (RT Motion-Tracking, Instance 2)
- Vault: Radiotherapy Vault 2
- Procedure: Fraction 18 of 30, 2 Gy delivery to right hilar mass
- Duration: Initiated at 23:48, treatment extends past midnight
- Status at 23:59: Field 2 of 3 in progress
- Beam gating efficiency (through 23:59): 93.8%
- Breathing amplitude: 3.6 mm (within tolerance)
- Marker displacement: 1.5 mm average (through 23:59)
- Treatment interruptions: 0

Minute-by-minute summary (through end of hour):
- 23:48 - Patient positioned, marker block placed on chest
- 23:49 - Calibration complete, breathing pattern established at 3.6 mm
- 23:50 - Beam-on, first field. Gating active.
- 23:54 - Field 1 complete (1.0 Gy delivered)
- 23:55 - Gantry rotation to field 2
- 23:56 - Beam-on, second field
- 23:59 - Field 2 in progress (0.4 Gy delivered so far). Continues next cycle.

Note: Treatment completion will be logged in the first hour of the next
24-hour cycle, demonstrating seamless inter-cycle continuity.

## Robot Utilization Summary

Active robots this hour: 3 of 29 instances (COMPN-02, IMAGE-02, TRACK-02)
Utilization rate: approximately 8%

| Robot | Instances | Active | Standby | Maintenance |
|-------|-----------|--------|---------|-------------|
| Surgical | 3 | 0 | 2 | 1 (SURG-01 PM) |
| Cobots | 4 | 0 | 4 | 0 |
| RT Positioning | 3 | 0 | 3 | 0 |
| Needle-Placement | 2 | 0 | 2 | 0 |
| Social Companion | 5 | 1 | 4 | 0 |
| Humanoids | 3 | 0 | 3 | 0 |
| RT Motion-Tracking | 3 | 1 | 2 | 0 |
| Imaging Assistant | 4 | 1 | 3 | 0 |
| Steerable Needle | 2 | 0 | 2 | 0 |
| Rehab Exoskeletons | 2 | 0 | 2 | 0 |
| Total | 29 | 3 | 25 | 1 |

## Night Shift Transition

At 23:00, SSO-N2 formally assumed site safety officer duties for the
overnight shift (23:00-07:00). SSO-N2 verified:
- Emergency stop systems functional across all bays and vaults
- Fire suppression and radiation shielding interlocks confirmed
- Night staffing levels adequate per site protocol (2 RNs, 1 RT, 1 SSO)
- All standby robots in safe home positions
- SURG-01 preventive maintenance area cordoned per lockout/tagout procedures

## Regulatory Compliance Notes

This simulation operates under:
- 21 CFR Part 11 (electronic records and signatures)
- 21 CFR Part 50 (informed consent)
- 21 CFR Part 812 (investigational device exemption framework)
- ICH E6(R2) Good Clinical Practice guidelines
- IEC 62304 (medical device software lifecycle)
- ISO 13482 (personal care robots safety)
- ISO 10218-1/2 (industrial robot safety, applicable to surgical/cobot systems)
- IAEA Safety Standards Series No. SSR-6 (radiation safety)

All patient interactions with Physical AI systems during this 24-hour cycle
were conducted under IRB-approved protocol PRO-2026-ODAI-001 with continuous
safety officer oversight.

## USL Framework Reference

The Unified Scaling Law (USL) framework (Kawchak, 2026;
DOI: 10.5281/zenodo.18778220) provides technical interoperability benchmarks
that complement the clinical PSL scores measured in this trial. Key USL
reference points remain:

| Robot Platform | USL Score | PSL Score (Hour 23) |
|----------------|-----------|---------------------|
| da Vinci dVRK | 7.1 | 7.0 (Surgical) |
| Franka Panda | 7.4 | 6.7 (Cobot) |
| Boston Dynamics Atlas | 5.8 | 5.8 (Humanoid) |

The 24-hour cycle demonstrates that PSL convergence toward USL benchmarks
occurs through sustained operational exposure, confirming that clinical
performance maturity correlates with but does not equal technical readiness.

## Patient Journey Note

The patient journey model validated across this 24-hour cycle follows:
Arrival (patient-chosen time) --> Check-in (kiosk, 2-3 min) --> Waiting
(variable, 3-15 min) --> Procedure (robot-assisted, 8-45 min depending on
type) --> Recovery/Discharge (variable). On-demand scheduling eliminated
the traditional appointment-slot constraint, enabling patients like
PAT-ODMND-0175 to receive care at times compatible with their personal
schedules. This represents a fundamental shift in oncology access.
